Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Immunomodulatory Biomaterials for Bone and Soft Tissue Chronic Inflammation Diseases

Li Y., Xie X., Ding C., Zhang S., Hu L., Mi B.

Narrative Review on Osteoarthritis, Disc Degeneration, Diabetic Foot, Spinal Cord Injury, published in Small Sci (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Small Sci (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41395518
PMCID
PMC12697878
DOI
10.1002/smsc.202500260
Citations
1

Abstract (original English)

Chronic inflammatory diseases of bone and soft tissue pose significant clinical challenges due to their complex pathogenesis and the limitations of conventional therapies, which often fail to address immune microenvironment dysregulation. This review explores the pivotal roles of key immune cells (including mast cells, macrophages, neutrophils, T cells, B cells, and dendritic cells) in driving inflammatory progression and tissue damage through dynamic cellular interactions and cytokine networks. It systematically analyzes the molecular and structural foundations of immunomodulatory biomaterials, such as nanoparticles, hydrogels, and scaffolds, which offer precise spatiotemporal control over immune cell phenotypes and inflammatory mediators. By integrating advances in immunology and materials science, this review highlights how surface functionalization, controlled drug release, and composite material strategies synergistically restore immune homeostasis and promote tissue regeneration. Studies across common chronic inflammatory diseases (e.g., osteoporosis, osteomyelitis, osteoarthritis, diabetic wounds, spinal cord injury, and intervertebral disc degeneration) demonstrate the therapeutic potential of biomaterial-mediated immunomodulation, such as nanoparticle-driven macrophage polarization, cytokine-loaded hydrogel-mediated immune cell balance, and scaffold-guided immune cell

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research